Kubota Vision Announces Publication in Scientific Reports; Effects of Using Projected Peripheral Myopic Defocus
Kubota Vision Inc. (Kubota Vision or the Company), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the publication of a new paper in the journal Scientific Reports, entitled Biometric and refractive changes following the monocular application of peripheral myopic defocus using a novel augmented-reality optical system in adults.
- Kubota Vision Inc. (Kubota Vision or the Company), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the publication of a new paper in the journal Scientific Reports, entitled Biometric and refractive changes following the monocular application of peripheral myopic defocus using a novel augmented-reality optical system in adults.
- This was a 4-month prospective clinical study conducted at MVA to investigate the effects of using projected peripheral myopic defocus in a benchtop optical system.
- The primary objective of the study was to assess the central axial length and cycloplegic refractive changes using a novel optical system and myopic defocus stimulus design.
- https://www.kubotavision.com/ ; https://www.kubotaholdings.co.jp/en/
Kubota Vision, the Kubota Vision logo and Kubota are registered trademarks or trademarks of Kubota Vision Inc. or Kubota Pharmaceutical Holdings in various jurisdictions.